|
1
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
International Agency for Research on
Cancer, . Latest global cancer data, 2020. GLOBOCAN database.
Available from:. https://www.iarc.fr/faq/latest-global-cancer-data-2020-qa/July
1–2021
|
|
3
|
Marzhoseyni Z, Shojaie L, Tabatabaei SA,
Movahedpour A, Safari M, Esmaeili D, Mahjoubin-Tehran M, Jalili A,
Morshedi K, Khan H, et al: Streptococcal bacterial components in
cancer therapy. Cancer Gene Ther. 29:141–155. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Neuzillet C, Tijeras-Raballand A, de
Mestier L, Cros J, Faivre S and Raymond E: MEK in cancer and cancer
therapy. Pharmacol Ther. 141:160–171. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rajappa A, Banerjee S, Sharma V and
Khandelia P: Circular RNAs: Emerging role in cancer diagnostics and
therapeutics. Front Mol Biosci. 7:5779382020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li X, Yang L and Chen LL: The biogenesis,
functions, and challenges of circular RNAs. Mol Cell. 71:428–442.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hsu MT and Coca-Prados M: Electron
microscopic evidence for the circular form of RNA in the cytoplasm
of eukaryotic cells. Nature. 280:339–340. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved, and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P
and Wu M: CircRNA: Functions and properties of a novel potential
biomarker for cancer. Mol Cancer. 16:942017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Z, Huang C, Bao C, Chen L, Lin M, Wang
X, Zhong G, Yu B, Hu W, Dai L, et al: Exon-intron circular RNAs
regulate transcription in the nucleus. Nat Struct Mol Biol.
22:256–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xie R, Zhang Y, Zhang J, Li J and Zhou X:
The role of circular RNAs in immune-related diseases. Front
Immunol. 11:5452020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang H, Shen Y, Li Z, Ruan Y, Li T, Xiao
B and Sun W: The biogenesis and biological functions of circular
RNAs and their molecular diagnostic values in cancers. J Clin Lab
Anal. 34:e230492020.PubMed/NCBI
|
|
13
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hentze MW and Preiss T: Circular RNAs:
Splicing's enigma variations. EMBO J. 32:923–925. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Du WW, Yang W, Liu E, Yang Z, Dhaliwal P
and Yang BB: Foxo3 circular RNA retards cell cycle progression via
forming ternary complexes with p21 and CDK2. Nucleic Acids Res.
44:2846–2858. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jeck WR and Sharpless NE: Detecting and
characterizing circular RNAs. Nat Biotechnol. 32:453–461. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Zhang XO, Chen T, Xiang JF, Yin
QF, Xing YH, Zhu S, Yang L and Chen LL: Circular intronic long
noncoding RNAs. Mol Cell. 51:792–806. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Legnini I, Di Timoteo G, Rossi F, Morlando
M, Briganti F, Sthandier O, Fatica A, Santini T, Andronache A, Wade
M, et al: Circ-ZNF609 is a circular RNA that can be translated and
functions in myogenesis. Mol Cell. 66:22–37.e9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang Y, Gao X, Zhang M, Yan S, Sun C, Xiao
F, Huang N, Yang X, Zhao K, Zhou H, et al: Novel role of FBXW7
circular RNA in repressing glioma tumorigenesis. J Natl Cancer
Inst. 110:304–315. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bramham CR and Wells DG: Dendritic mRNA:
Transport, translation and function. Nat Rev Neurosci. 8:776–789.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z
and Sharpless NE: Expression of linear and novel circular forms of
an INK4/ARF-associated non-coding RNA correlates with
atherosclerosis risk. PLoS Genet. 6:e10012332010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu H, Guo S, Li W and Yu P: The circular
RNA Cdr1as, via miR-7 and its targets, regulates insulin
transcription and secretion in islet cells. Sci Rep. 5:124532015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma X, Wang C, Chen J, Wei D, Yu F and Sun
J: circAGFG1 sponges miR-28-5p to promote non-small-cell lung
cancer progression through modulating HIF-1α level. Open Med
(Wars). 16:703–717. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cao L, Wang M, Dong Y, Xu B, Chen J, Ding
Y, Qiu S, Li L, Karamfilova Zaharieva E, Zhou X and Xu Y: Circular
RNA circRNF20 promotes breast cancer tumorigenesis and Warburg
effect through miR-487a/HIF-1α/HK2. Cell Death Dis. 11:1452020.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu J, Liu H, Zeng Q, Xu P, Liu M and Yang
N: Circular RNA circ-MAT2B facilitates glycolysis and growth of
gastric cancer through regulating the miR-515-5p/HIF-1α axis.
Cancer Cell Int. 20:1712020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Su Y, Yang W, Jiang N, Shi J, Chen L,
Zhong G, Bi J, Dong W, Wang Q, Wang C and Lin T: Hypoxia-elevated
circELP3 contributes to bladder cancer progression and cisplatin
resistance. Int J Biol Sci. 15:441–452. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Prabhakar NR and Semenza GL: Adaptive and
maladaptive cardiorespiratory responses to continuous and
intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.
Physiol Rev. 92:967–1003. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Albadari N, Deng S and Li W: The
transcriptional factors HIF-1 and HIF-2 and their novel inhibitors
in cancer therapy. Expert Opin Drug Discov. 14:667–682. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Murugesan T, Rajajeyabalachandran G, Kumar
S, Nagaraju S and Jegatheesan SK: Targeting HIF-2α as therapy for
advanced cancers. Drug Discov Today. 23:1444–1451. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Heikkilä M, Pasanen A, Kivirikko KI and
Myllyharju J: Roles of the human hypoxia-inducible factor (HIF)-3α
variants in the hypoxia response. Cell Mol Life Sci. 68:3885–3901.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Semenza GL: Oxygen sensing,
hypoxia-inducible factors, and disease pathophysiology. Annu Rev
Pathol. 9:47–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wenger RH, Stiehl DP and Camenisch G:
Integration of oxygen signaling at the consensus HRE. Sci STKE.
2005:re122005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brown JM: Evidence for acutely hypoxic
cells in mouse tumours, and a possible mechanism of reoxygenation.
Br J Radiol. 52:650–656. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Höckel M and Vaupel P: Tumor hypoxia:
Definitions and current clinical, biologic, and molecular aspects.
J Natl Cancer Inst. 93:266–276. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lu H, Forbes RA and Verma A:
Hypoxia-inducible factor 1 activation by aerobic glycolysis
implicates the Warburg effect in carcinogenesis. J Biol Chem.
277:23111–23115. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Marín-Hernández A, Gallardo-Pérez JC,
Ralph SJ, Rodríguez-Enríquez S and Moreno-Sánchez R: HIF-1alpha
modulates energy metabolism in cancer cells by inducing
over-expression of specific glycolytic isoforms. Mini Rev Med Chem.
9:1084–1101. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Semenza GL: Cancer-stromal cell
interactions mediated by hypoxia-inducible factors promote
angiogenesis, lymphangiogenesis, and metastasis. Oncogene.
32:4057–4063. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chouaib S, Kieda C, Benlalam H, Noman MZ,
Mami-Chouaib F and Rüegg C: Endothelial cells as key determinants
of the tumor microenvironment: Interaction with tumor cells,
extracellular matrix and immune killer cells. Crit Rev Immunol.
30:529–545. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Johnson BF, Clay TM, Hobeika AC, Lyerly HK
and Morse MA: Vascular endothelial growth factor and
immunosuppression in cancer: Current knowledge and potential for
new therapy. Expert Opin Biol Ther. 7:449–460. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Woo SR, Corrales L and Gajewski TF: Innate
immune recognition of cancer. Annu Rev Immunol. 33:445–474. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nishi H, Nakada T, Hokamura M, Osakabe Y,
Itokazu O, Huang LE and Isaka K: Hypoxia-inducible factor-1
transactivates transforming growth factor-beta3 in trophoblast.
Endocrinology. 145:4113–418. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lan L, Luo Y, Cui D, Shi BY, Deng W, Huo
LL, Chen HL, Zhang GY and Deng LL: Epithelial-mesenchymal
transition triggers cancer stem cell generation in human thyroid
cancer cells. Int J Oncol. 43:113–120. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Schwab LP, Peacock DL, Majumdar D, Ingels
JF, Jensen LC, Smith KD, Cushing RC and Seagroves TN:
Hypoxia-inducible factor 1α promotes primary tumor growth and
tumor-initiating cell activity in breast cancer. Breast Cancer Res.
14:R62012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Calvani M, Comito G, Giannoni E and
Chiarugi P: Time-dependent stabilization of hypoxia inducible
factor-1α by different intracellular sources of reactive oxygen
species. PLoS One. 7:e383882012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Seebacher NA, Richardson DR and Jansson
PJ: Glucose modulation induces reactive oxygen species and
increases P-glycoprotein-mediated multidrug resistance to
chemotherapeutics. Br J Pharmacol. 172:2557–2572. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cheng X, Qiu J, Wang S, Yang Y, Guo M,
Wang D, Luo Q and Xu L: Comprehensive circular RNA profiling
identifies CircFAM120A as a new biomarker of hypoxic lung
adenocarcinoma. Ann Transl Med. 7:4422019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Feng D, Xu Y, Hu J, Zhang S, Li M and Xu
L: A novel circular RNA, hsa-circ-0000211, promotes lung
adenocarcinoma migration and invasion through sponging of
hsa-miR-622 and modulating HIF1-α expression. Biochem Biophys Res
Commun. 521:395–401. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yu L, Li J, Peng B, Cai P, Zhao B, Chen Y
and Zhu H: CircASXL1 knockdown restrains hypoxia-induced DDP
resistance and NSCLC progression by sponging miR-206. Cancer Manag
Res. 13:5077–5089. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J,
Chen D, Gu J, He X and Huang S: Circular RNA is enriched and stable
in exosomes: A promising biomarker for cancer diagnosis. Cell Res.
25:981–984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liu KH, Tsai YT, Chin SY, Lee WR, Chen YC
and Shen SC: Hypoxia stimulates the epithelial-to-mesenchymal
transition in lung cancer cells through accumulation of nuclear
β-catenin. Anticancer Res. 38:6299–6308. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chi Y, Luo Q, Song Y, Yang F, Wang Y, Jin
M and Zhang D: Circular RNA circPIP5K1A promotes non-small cell
lung cancer proliferation and metastasis through miR-600/HIF-1α
regulation. J Cell Biochem. 120:19019–19030. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Thompson B, Hohl SD, Molina Y, Paskett ED,
Fisher JL, Baltic RD and Washington CM: Breast cancer disparities
among women in underserved communities in the USA. Curr Breast
Cancer Rep. 10:131–141. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Liang G, Liu Z, Tan L, Su AN, Jiang WG and
Gong C: HIF1α-associated circDENND4C promotes proliferation of
breast cancer cells in hypoxic environment. Anticancer Res.
37:4337–4343. 2017.PubMed/NCBI
|
|
54
|
Wang J, Huang K, Shi L, Zhang Q and Zhang
S: CircPVT1 Promoted the progression of breast cancer by regulating
MiR-29a-3p-mediated AGR2-HIF-1α pathway. Cancer Manag Res.
12:11477–11490. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Darbeheshti F, Mahdiannasser M, Noroozi Z,
Firoozi Z, Mansoori B, Daraei A, Bastami M, Nariman-Saleh-Fam Z,
Valipour E and Mansoori Y: Circular RNA-associated ceRNA network
involved in HIF-1 signalling in triple-negative breast cancer:
circ_0047303 as a potential key regulator. J Cell Mol Med.
25:11322–11332. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Arnold M, Abnet CC, Neale RE, Vignat J,
Giovannucci EL, McGlynn KA and Bray F: Global burden of 5 major
types of gastrointestinal cancer. Gastroenterology.
159:335–349.e15. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Singh D, Arora R, Kaur P, Singh B, Mannan
R and Arora S: Overexpression of hypoxia-inducible factor and
metabolic pathways: Possible targets of cancer. Cell Biosci.
7:622017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Xing X, Liang D, Huang Y, Zeng Y, Han X,
Liu X and Liu J: The application of proteomics in different aspects
of hepatocellular carcinoma research. J Proteomics. 145:70–80.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhai Z, Fu Q, Liu C, Zhang X, Jia P, Xia
P, Liu P, Liao S, Qin T and Zhang H: Emerging roles of
hsa-circ-0046600 targeting the miR-640/HIF-1α signalling pathway in
the progression of HCC. Onco Targets Ther. 12:9291–9302. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Tu Q, You X, He J, Hu X, Xie C and Xu G:
Circular RNA Circ-0003006 promotes hepatocellular carcinoma
proliferation and metastasis through sponging miR-542-3p and
regulating HIF-1A. Cancer Manag Res. 13:7859–7870. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Tan Y, Du B, Zhan Y, Wang K, Wang X, Chen
B, Wei X and Xiao J: Antitumor effects of circ-EPHB4 in
hepatocellular carcinoma via inhibition of HIF-1α. Mol Carcinog.
58:875–886. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Mizrahi JD, Surana R, Valle JW and Shroff
RT: Pancreatic cancer. Lancet. 395:2008–2020. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Yang J, Ren B, Yang G, Wang H, Chen G, You
L, Zhang T and Zhao Y: The enhancement of glycolysis regulates
pancreatic cancer metastasis. Cell Mol Life Sci. 77:305–321. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Liu A and Xu J: Circ_03955 promotes
pancreatic cancer tumorigenesis and Warburg effect by targeting the
miR-3662/HIF-1α axis. Clin Transl Oncol. 23:1905–1914. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Barsoum IB, Hamilton TK, Li X, Cotechini
T, Miles EA, Siemens DR and Graham CH: Hypoxia induces escape from
innate immunity in cancer cells via increased expression of ADAM10:
Role of nitric oxide. Cancer Res. 71:7433–7441. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Lu Y, Hu J, Sun W, Duan X and Chen X:
Hypoxia-mediated immune evasion of pancreatic carcinoma cells. Mol
Med Rep. 11:3666–3672. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Ou ZL, Luo Z, Wei W, Liang S, Gao TL and
Lu YB: Hypoxia-induced shedding of MICA and HIF1A-mediated immune
escape of pancreatic cancer cells from NK cells: Role of
circ_0000977/miR-153 axis. RNA Biol. 16:1592–1603. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Harada S and Morlote D: Molecular
pathology of colorectal cancer. Adv Anat Pathol. 27:20–26. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Vasaikar S, Huang C, Wang X, Petyuk VA,
Savage SR, Wen B, Dou Y, Zhang Y, Shi Z, Arshad OA, et al:
Proteogenomic analysis of human colon cancer reveals new
therapeutic opportunities. Cell. 177:1035–1049.e19. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Chen LY, Wang L, Ren YX, Pang Z, Liu Y,
Sun XD, Tu J, Zhi Z, Qin Y, Sun LN and Li JM: The circular RNA
circ-ERBIN promotes growth and metastasis of colorectal cancer by
miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α
translation. Mol Cancer. 19:1642020. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhou P, Xie W, Huang HL, Huang RQ, Tian C,
Zhu HB, Dai YH and Li ZY: circRNA_100859 functions as an oncogene
in colon cancer by sponging the miR-217-HIF-1α pathway. Aging
(Albany NY). 12:13338–13353. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Qian W, Huang T and Feng W: Circular RNA
HIPK3 promotes EMT of cervical cancer through sponging miR-338-3p
to Up-regulate HIF-1α. Cancer Manag Res. 12:177–187. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Chen H, Mao M, Jiang J, Zhu D and Li P:
Circular RNA CDR1as acts as a sponge of miR-135b-5p to suppress
ovarian cancer progression. Onco Targets Ther. 12:3869–3879. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Su H, Zou D, Sun Y and Dai Y:
Hypoxia-associated circDENND2A promotes glioma aggressiveness by
sponging miR-625-5p. Cell Mol Biol Lett. 24:242019. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Matulonis UA: Ovarian cancer. Hematol
Oncol Clin North Am. 32:13–14. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Bleeker FE, Molenaar RJ and Leenstra S:
Recent advances in the molecular understanding of glioblastoma. J
Neurooncol. 108:11–27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Li Y and Ye D: Cancer therapy by targeting
hypoxia-inducible factor-1. Curr Cancer Drug Targets. 10:782–796.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Yang W, Liu Y, Gao R, Xiu Z and Sun T:
Knockdown of cZNF292 suppressed hypoxic human hepatoma SMMC7721
cell proliferation, vasculogenic mimicry, and radioresistance. Cell
Signal. 60:122–135. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Li K, Guo J, Wu Y, Jin D, Jiang H, Liu C
and Qin C: Suppression of YAP by DDP disrupts colontumor
progression. Oncol Rep. 39:2114–2126. 2018.PubMed/NCBI
|
|
81
|
Xu Y, Jiang T, Wu C and Zhang Y: CircAKT3
inhibits glycolysis balance in lung cancer cells by regulating
miR-516b-5p/STAT3 to inhibit cisplatin sensitivity. Biotechnol
Lett. 42:1123–1135. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Xu G, Li M, Wu J, Qin C, Tao Y and He H:
Circular RNA circNRIP1 sponges microRNA-138-5p to maintain
hypoxia-induced resistance to 5-fluorouracil through
HIF-1α-dependent glucose metabolism in gastric carcinoma. Cancer
Manag Res. 12:2789–2802. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Zeng Z, Zhao Y, Chen Q, Zhu S, Niu Y, Ye
Z, Hu P, Chen D, Xu P, Chen J, et al: Hypoxic exosomal
HIF-1α-stabilizing circZNF91 promotes chemoresistance of normoxic
pancreatic cancer cells via enhancing glycolysis. Oncogene.
40:5505–5517. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Yang Z, Xie L, Han L, Qu X, Yang Y, Zhang
Y, He Z, Wang Y and Li J: Circular RNAs: Regulators of
cancer-related signaling pathways and potential diagnostic
biomarkers for human cancers. Theranostics. 7:3106–3117. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Vaupel P and Mayer A: Hypoxia in tumors:
Pathogenesis-related classification, characterization of hypoxia
subtypes, and associated biological and clinical implications. Adv
Exp Med Biol. 812:19–24. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Cheng SC, Quintin J, Cramer RA, Shepardson
KM, Saeed S, Kumar V, Giamarellos-Bourboulis EJ, Martens JH, Rao
NA, Aghajanirefah A, et al: mTOR- and HIF-1α-mediated aerobic
glycolysis as metabolic basis for trained immunity. Science.
345:12506842014. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Balamurugan K: HIF-1 at the crossroads of
hypoxia, inflammation, and cancer. Int J Cancer. 138:1058–1066.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Jiang YG, Luo Y, He DL, Li X, Zhang LL,
Peng T, Li MC and Lin YH: Role of Wnt/beta-catenin signaling
pathway in epithelial-mesenchymal transition of human prostate
cancer induced by hypoxia-inducible factor-1alpha. Int J Urol.
14:1034–1039. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Lavecchia A, Di Giovanni C and Cerchia C:
Novel inhibitors of signal transducer and activator of
transcription 3 signaling pathway: An update on the recent patent
literature. Expert Opin Ther Pat. 24:383–400. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Brown JM: Tumor microenvironment and the
response to anticancer therapy. Cancer Biol Ther. 1:453–458. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Doktorova H, Hrabeta J, Khalil MA and
Eckschlager T: Hypoxia-induced chemoresistance in cancer cells: The
role of not only HIF-1. Biomed Pap Med Fac Univ Palacky Olomouc
Czech Repub. 159:166–177. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Wigerup C, Påhlman S and Bexell D:
Therapeutic targeting of hypoxia and hypoxia-inducible factors in
cancer. Pharmacol Ther. 164:152–169. 2016. View Article : Google Scholar : PubMed/NCBI
|
